Skip to main content
    I

    ImageneBio, Inc. (IMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.20
    -0.27 (-7.78%)

    Market Cap: $43.22M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    ImageneBio, Inc. (IMA) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    ImageneBio (IMA) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, ImageneBio reported EPS of -$0.91, below the -$0.83 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    32%(7/22)
    Avg Surprise
    -31.15%

    Upcoming Estimates

    Reports Mar 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.97
    Range-$1.00 - -$0.96
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.14
    Range-$1.14 - -$1.14
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.99-15.2%
    60d ago-$1.07-7.0%
    30d ago-$1.07-7.0%
    7d ago-$1.07-7.0%
    Current-$1.14
    Revenue Consensus
    N/A
    RangeN/A
    2 analysts

    Next Report

    IMA has an expected report date of Mar 1, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, IMA beat 7, missed 5 and matched 10. The widest gap in the table came in the quarter ended Jun 30, 2025, when EPS landed 386.94% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.91-$0.83-$0.98 - -$0.72-9.64%MissN/A32 up, 0 downNov 9, 2026N/A
    Jun 30, 2026-$0.63-$0.90-$1.23 - -$0.72+30.00%BeatN/A31 up, 1 downJul 23, 2026N/A
    Mar 31, 2026-$0.95-$0.66-$0.66 - -$0.66-43.94%MissN/A10 up, 0 downMay 7, 2026N/A
    Dec 31, 2025-$0.62-$1.15N/A+46.28%BeatN/A10 up, 0 downMar 10, 2026$800000
    Sep 30, 2025-$2.91-$1.00-$1.00 - -$1.00-191.00%MissN/A10 up, 0 downNov 12, 2025N/A
    Jun 30, 2025-$0.69-$0.14N/A-386.94%MissN/AN/AN/AJul 24, 2025N/A
    Mar 31, 2025-$0.17-$0.19N/A+11.41%BeatN/AN/AN/AMay 8, 2025$800000
    Dec 31, 2024-$0.20-$0.21N/A+3.24%BeatN/AN/AN/AMar 6, 2025N/A
    Sep 30, 2024-$0.21-$0.25N/A+17.61%BeatN/AN/AN/ANov 7, 2024$3.50M
    Jun 30, 2024-$0.28-$0.36N/A+22.22%BeatN/AN/AN/AAug 8, 2024N/A
    Mar 31, 2024-$0.33-$0.33N/A0.00%In lineN/AN/AN/AMay 13, 2024N/A
    Dec 31, 2023-$0.41-$0.41N/A0.00%In lineN/AN/AN/AMar 12, 2024$658000
    Sep 30, 2023-$0.40-$0.40N/A0.00%In lineN/AN/AN/ANov 9, 2023$1.19M
    Jun 30, 2023-$0.44-$0.44N/A0.00%In lineN/AN/AN/AAug 10, 2023$2.00M
    Mar 31, 2023-$0.39-$0.39N/A0.00%In lineN/AN/AN/AMay 15, 2023$5.31M
    Dec 31, 2022-$0.39-$0.39N/A0.00%In line-657.1%N/AN/AMar 14, 2023$5.45M
    Sep 30, 2022-$0.48-$0.48N/A0.00%In lineN/AN/AN/ANov 7, 2022$6.40M
    Jun 30, 2022-$0.57-$0.57N/A0.00%In lineN/AN/AN/AAug 11, 2022$382000
    Mar 31, 2022-$0.47-$0.47N/A0.00%In lineN/AN/AN/AMay 12, 2022$3.38M
    Dec 31, 2021$0.07$0.07N/A0.00%In lineN/AN/AN/AMar 17, 2022$20.22M
    Sep 30, 2021-$0.40-$0.42N/A+4.76%BeatN/AN/AN/ANov 10, 2021$3.75M
    Jun 30, 2021-$1.89N/AN/AN/AN/AN/AN/AN/AAug 12, 2021$3.55M
    Mar 31, 2021-$2.52-$0.87N/A-189.22%MissN/AN/AN/AMay 13, 2021$3.47M
    Dec 31, 2020-$0.15N/AN/AN/AN/AN/AN/AN/AMar 26, 2021$65000
    Last 24 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.39, after -$1.02 the year before. It was -$0.15 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.39N/A
    Dec 31, 2024-$1.02N/A
    Dec 31, 2023-$1.64N/A
    Dec 31, 2022-$1.91N/A
    Dec 31, 2021-$4.74N/A
    Dec 31, 2020-$0.15N/A

    Frequently Asked Questions About IMA

    When is ImageneBio's next earnings date?

    ImageneBio's next earnings report is expected for Mar 1, 2027.

    Did IMA beat earnings estimates last quarter?

    No. ImageneBio reported EPS of -$0.91 for the quarter ended Sep 30, 2026, below the -$0.83 estimate by 9.64%.

    What EPS do analysts expect from IMA next quarter?

    The consensus EPS estimate for ImageneBio for the quarter ending Dec 31, 2026 is -$0.97 from 5 analysts, with estimates from -$1.00 to -$0.96.

    How often does IMA beat earnings estimates?

    ImageneBio beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -67.57%.